Clinical Trials on Retinal Dystrophies in Belgium

Total 430 results

Nano Retina
MedPass International

Terminated

NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases (NR)

Retinal Degeneration | Retinitis Pigmentosa

Belgium, Israel, Italy
Universitaire Ziekenhuizen KU Leuven

Completed

EVA Nexus Vitrectomy Device Field Observation Study

Vitreous Disorder | Retina Disorder

Belgium
Janssen Research & Development, LLC
Janssen Research & Development, LLC

Active, not recruiting

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

X-Linked Retinitis Pigmentosa

United States, Canada, Israel, United Kingdom, Spain, Denmark, France, Belgium, Italy, Netherlands, Switzerland
Janssen Research & Development, LLC
Janssen Research & Development, LLC

Active, not recruiting

Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

X-Linked Retinitis Pigmentosa

Belgium, Canada, United States, Israel, United Kingdom, Spain, Denmark, France, Italy, Netherlands, Switzerland
ProQR Therapeutics

Recruiting

An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. (BRIGHTEN)

Eye Diseases | Neurologic Manifestations | Retinal Degeneration | Retinal Dystrophies | Sensation Disorders | Vision Disorders | Blindness | Leber Congenital Amaurosis | Leber Congenital Amaurosis 10 | Retinal Disease | Eye Disorders Congenital

Belgium, Brazil, Canada, Germany, Italy, Netherlands, United Kingdom
Cliniques universitaires Saint-Luc- Université...

Recruiting

Arterial Spin Labeling MRI for Assessing Blood Perfusion in the Human Eye Repeatability Study and Clinical Application (PerfRet)

Retinal Diseases

Belgium
Brugmann University Hospital

Completed

Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.

Macular Degeneration

Belgium
University Hospital, Ghent

Recruiting

Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema

Macular Edema | Retinal Neovascularization

Belgium
Laurence Postelmans

Completed

Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann

Age-related Macular Degeneration

Belgium
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Surgical Stabilizer Assisted RVC With rtPA for CRVO

Central Retinal Vein Occlusion

Belgium
Universitaire Ziekenhuizen KU Leuven
Fund for Scientific Research, Flanders, Belgium; Funds for Research in Ophthalmology... and other collaborators

Completed

The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy

Fuchs' Endothelial Dystrophy

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Zeiss RESIGHT Disposable Lenses Evaluation Study (RESIGHT)

Retinal Detachment | Macular Holes | Vitreomacular Traction | Macular Pucker

Belgium
Brugmann University Hospital

Completed

Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular Edema

Macular Edema

Belgium
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Beovu Experience UZ Leuven (BEL)

Age-Related Macular Degeneration

Belgium
Brugmann University Hospital

Completed

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Age-Related Macular Degeneration

Belgium
Brugmann University Hospital

Completed

Effectiveness of Anti-VEGF Treatments in Wet AMD in Active Smokers

Wet Age-related Macular Degeneration

Belgium
Allergan

Completed

Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

Retinal Vein Occlusion | Macular Oedema

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Phase I RVC With Ocriplasmin for CRVO (RVC_CRVO)

Central Retinal Vein Occlusion

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Visual Outcome After Vitrectomy With Subretinal tPA Injection (EVA-tPA)

Age-Related Macular Degeneration

Belgium
Hasselt University

Unknown

Changes in Microcirculation and Functional Status During Exacerbation of COPD (COPD-EX)

Physical Activity | COPD Exacerbation | Retinal Vascular

Belgium
Bayer
Regeneron Pharmaceuticals

Completed

Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion (RETRO CRVO)

Retinal Vein Occlusion

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains (NewBlueDyes)

Macular Holes | Vitreomacular Traction | Macular Pucker

Belgium
Bayer

Completed

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD). (BELUGA)

Neovascular Age-related Macular Degeneration

Belgium
Universitaire Ziekenhuizen KU Leuven
Laboratoires Thea

Completed

Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD (OVID-AMD)

Age-related Macular Degeneration | Vitamin D Deficiency

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Compare ELP in Patients With Elective Phaco-VTX Surgery in One Eye and a Single Lens Phaco Surgery on the Other Eye (ELP)

Macular Pucker

Belgium
ThromboGenics

Completed

Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy

Eye Diseases | Vitreomacular Traction Maculopathy

Belgium, Netherlands
Pfizer

Completed

A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life. (MACURELI)

Neovascular Age-related Macular Degeneration

Belgium
Universitaire Ziekenhuizen KU Leuven
DORC Dutch Ophthalmic Research Center International BV

Recruiting

Robotic Subretinal tPA Injection Study (RoTIS)

Age-Related Macular Degeneration | Subretinal Hemorrhage

Belgium
Santhera Pharmaceuticals

Completed

Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)

Duchenne Muscular Dystrophy

Belgium
Sheba Medical Center
Universitaire Ziekenhuizen KU Leuven

Unknown

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD) (AMD)

Neovascular Age Related Macular Degeneration

Belgium, Israel
Santhera Pharmaceuticals

Completed

Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy (DELPHI)

Duchenne Muscular Dystrophy (DMD)

Belgium
Laurent Servais
SYSNAV

Recruiting

Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

Duchenne Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy

Belgium
Laurence Postelmans

Completed

Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients

Epiretinal Membrane

Belgium
Devogelaere Vision

Completed

Effect of Vitamin Supplementation in Glaucoma Patients

Glaucoma | Homocysteinemia | Elevated Retinal Venous Pressure | Abnormal Steady State Pattern Electroretinography

Belgium
UMC Utrecht
Universitaire Ziekenhuizen KU Leuven; Maastricht University Medical Center; Carl...

Completed

The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation (ADVISE)

Vision Disorders | Fuchs Dystrophy | Bullous Keratopathy | Endothelial Corneal Dystrophy

Netherlands, Belgium
Vrije Universiteit Brussel

Completed

Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1

Myotonic Dystrophy 1

Belgium
Acusurgical

Recruiting

A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases

Vitreoretinal Disease

Belgium
University Hospital, Ghent

Completed

Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency

Acute Renal Failure | Chronic Renal Failure

Belgium
University Hospital, Ghent

Completed

Solute Removal With High Volume Hemodiafiltration Versus Long High Flux Hemodialysis

End-stage Renal Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Reasons for Mycophenolate Mofetil Dose Reduction and Impact on Graft Outcome in Renal Transplant Recipients

Acute Rejection of Renal Transplant | Renal Graft Loss

Belgium
Guerbet

Completed

Safety and Dialysability of Dotarem® in Dialysed Patients

End-stage Renal Failure

Belgium
BioMarin Pharmaceutical

Completed

Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

Belgium, Netherlands, Italy, Sweden
University Hospital, Ghent

Withdrawn

Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis

Renal Failure, Chronic

Belgium
University Hospital, Ghent

Completed

Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard Dialysis

Chronic Renal Failure

Belgium
Ziekenhuis Netwerk Antwerpen (ZNA)

Terminated

Intermittent Versus Continuous Renal Replacement Therapy for Acute Renal Failure

Renal Replacement Therapy | Renal Insufficiency, Acute

Belgium
University Hospital, Ghent
Gambro Corporate Research, Sweden

Completed

Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment.

Chronic Renal Failure

Belgium
Universitair Ziekenhuis Brussel

Completed

Evaluation of Contact Phase Activation During Hemodialysis (c-phact)

End Stage Renal Disease

Belgium
Sarepta Therapeutics, Inc.

Completed

Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping

Duchenne Muscular Dystrophy

Belgium, France, Italy, United Kingdom
BioMarin Pharmaceutical

Terminated

Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

Belgium, Netherlands, Italy, Sweden
BioMarin Pharmaceutical

Terminated

Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

Netherlands, Belgium, Italy, Sweden

Clinical Trials on Retinal Dystrophies in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations